25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Cardiol Therapeutics Inc Class A
Buy, Hold or Sell?

Let's analyze Cardiol Therapeutics Inc Class A together

I guess you are interested in Cardiol Therapeutics Inc Class A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cardiol Therapeutics Inc Class A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cardiol Therapeutics Inc Class A

I send you an email if I find something interesting about Cardiol Therapeutics Inc Class A.

1. Quick Overview

1.1. Quick analysis of Cardiol Therapeutics Inc Class A (30 sec.)










1.2. What can you expect buying and holding a share of Cardiol Therapeutics Inc Class A? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$0.19
Expected worth in 1 year
C$-0.10
How sure are you?
22.2%

+ What do you gain per year?

Total Gains per Share
C$-0.29
Return On Investment
-11.3%

For what price can you sell your share?

Current Price per Share
C$2.61
Expected price per share
C$2.14 - C$3.57
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cardiol Therapeutics Inc Class A (5 min.)




Live pricePrice per Share (EOD)
C$2.61
Intrinsic Value Per Share
C$-1.60 - C$-1.78
Total Value Per Share
C$-1.40 - C$-1.59

2.2. Growth of Cardiol Therapeutics Inc Class A (5 min.)




Is Cardiol Therapeutics Inc Class A growing?

Current yearPrevious yearGrowGrow %
How rich?$11m$34.9m-$17.3m-98.1%

How much money is Cardiol Therapeutics Inc Class A making?

Current yearPrevious yearGrowGrow %
Making money-$5.2m-$4.8m-$416.3k-7.9%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Cardiol Therapeutics Inc Class A (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cardiol Therapeutics Inc Class A?

Welcome investor! Cardiol Therapeutics Inc Class A's management wants to use your money to grow the business. In return you get a share of Cardiol Therapeutics Inc Class A.

First you should know what it really means to hold a share of Cardiol Therapeutics Inc Class A. And how you can make/lose money.

Speculation

The Price per Share of Cardiol Therapeutics Inc Class A is C$2.605. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cardiol Therapeutics Inc Class A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cardiol Therapeutics Inc Class A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.19. Based on the TTM, the Book Value Change Per Share is C$-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cardiol Therapeutics Inc Class A.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.06-2.3%-0.07-2.5%-0.07-2.6%-0.06-2.3%-0.05-2.0%
Usd Book Value Change Per Share-0.04-1.6%-0.05-2.0%-0.05-2.1%0.00-0.1%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.04-1.6%-0.05-2.0%-0.05-2.1%0.00-0.1%0.010.2%
Usd Price Per Share1.96-1.34-0.71-1.75-1.68-
Price to Earnings Ratio-8.24--5.13--2.56--8.82--8.90-
Price-to-Total Gains Ratio-46.25--27.13--14.27--33.01--92.00-
Price to Book Ratio14.14-7.43-1.64-8.81-8.54-
Price-to-Total Gains Ratio-46.25--27.13--14.27--33.01--92.00-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.867264
Number of shares535
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.00
Usd Total Gains Per Share-0.050.00
Gains per Quarter (535 shares)-28.18-1.02
Gains per Year (535 shares)-112.70-4.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-113-1230-4-14
20-225-2360-8-18
30-338-3490-12-22
40-451-4620-16-26
50-564-5750-20-30
60-676-6880-24-34
70-789-8010-28-38
80-902-9140-33-42
90-1014-10270-37-46
100-1127-11400-41-50

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.027.00.00.0%0.027.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%6.020.01.022.2%6.020.01.022.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.027.00.0%0.00.027.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%6.020.01.022.2%6.020.01.022.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cardiol Therapeutics Inc Class A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.059-0.073+24%-0.076+28%-0.003-96%0.007-926%
Book Value Per Share--0.1930.310-38%0.613-69%0.433-55%0.352-45%
Current Ratio--2.3943.711-35%6.537-63%9.243-74%10.028-76%
Debt To Asset Ratio--0.4160.298+40%0.153+171%0.151+175%0.208+100%
Debt To Equity Ratio--0.7130.450+59%0.182+292%0.195+265%0.611+17%
Dividend Per Share----0%-0%-0%-0%
Eps---0.083-0.092+11%-0.096+15%-0.084+2%-0.073-11%
Free Cash Flow Per Share---0.060-0.068+13%-0.092+53%-0.064+7%-0.056-7%
Free Cash Flow To Equity Per Share---0.059-0.067+14%-0.092+56%0.005-1398%0.008-846%
Gross Profit Margin--1.0091.132-11%1.000+1%1.026-2%1.020-1%
Intrinsic Value_10Y_max---1.785--------
Intrinsic Value_10Y_min---1.595--------
Intrinsic Value_1Y_max---0.294--------
Intrinsic Value_1Y_min---0.289--------
Intrinsic Value_3Y_max---0.795--------
Intrinsic Value_3Y_min---0.761--------
Intrinsic Value_5Y_max---1.191--------
Intrinsic Value_5Y_min---1.113--------
Market Cap207318404.000-5%217266504.000149221500.000+46%78391028.000+177%193987950.000+12%186434762.963+17%
Net Profit Margin----0%-0%-4.1650%-3.0850%
Operating Margin----0%-0%-3.9740%-2.9440%
Operating Ratio----0%-0%4.128-100%3.058-100%
Pb Ratio13.496-5%14.1447.429+90%1.635+765%8.809+61%8.536+66%
Pe Ratio-7.864+5%-8.241-5.134-38%-2.561-69%-8.819+7%-8.904+8%
Price Per Share2.605-5%2.7301.875+46%0.985+177%2.438+12%2.343+17%
Price To Free Cash Flow Ratio-10.844+5%-11.364-7.235-36%-3.236-72%-13.191+16%-12.627+11%
Price To Total Gains Ratio-44.129+5%-46.247-27.130-41%-14.266-69%-33.010-29%-92.004+99%
Quick Ratio--2.2453.559-37%6.341-65%7.381-70%7.925-72%
Return On Assets---0.250-0.223-11%-0.120-52%-0.204-18%-0.208-17%
Return On Equity---0.429-0.332-23%-0.142-67%-0.248-42%-0.281-35%
Total Gains Per Share---0.059-0.073+24%-0.076+28%-0.003-96%0.007-926%
Usd Book Value--11010906.72617657947.418-38%34977045.197-69%24685866.025-55%20070404.142-45%
Usd Book Value Change Per Share---0.042-0.053+24%-0.054+28%-0.002-96%0.005-926%
Usd Book Value Per Share--0.1380.222-38%0.439-69%0.310-55%0.252-45%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.059-0.066+11%-0.069+15%-0.060+2%-0.053-11%
Usd Free Cash Flow---3425947.750-3870957.440+13%-5237175.014+53%-3674112.010+7%-3189693.178-7%
Usd Free Cash Flow Per Share---0.043-0.049+13%-0.066+53%-0.046+7%-0.040-7%
Usd Free Cash Flow To Equity Per Share---0.042-0.048+14%-0.066+56%0.003-1398%0.006-846%
Usd Market Cap148605831.987-5%155736630.067106961971.200+46%56190688.870+177%139050562.560+12%133636438.092+17%
Usd Price Per Share1.867-5%1.9571.344+46%0.706+177%1.747+12%1.679+17%
Usd Profit---4724337.766-5257317.094+11%-4840994.278+2%-4691065.989-1%-4101811.302-13%
Usd Revenue----0%-0%2822.758-100%2090.932-100%
Usd Total Gains Per Share---0.042-0.053+24%-0.054+28%-0.002-96%0.005-926%
 EOD+3 -5MRQTTM+17 -13YOY+18 -125Y+9 -2310Y+5 -27

3.3 Fundamental Score

Let's check the fundamental score of Cardiol Therapeutics Inc Class A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.864
Price to Book Ratio (EOD)Between0-113.496
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.245
Current Ratio (MRQ)Greater than12.394
Debt to Asset Ratio (MRQ)Less than10.416
Debt to Equity Ratio (MRQ)Less than10.713
Return on Equity (MRQ)Greater than0.15-0.429
Return on Assets (MRQ)Greater than0.05-0.250
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Cardiol Therapeutics Inc Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.509
Ma 20Greater thanMa 502.597
Ma 50Greater thanMa 1002.728
Ma 100Greater thanMa 2002.804
OpenGreater thanClose2.510
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Cardiol Therapeutics Inc Class A

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Fundamental data was last updated by Penke on 2024-10-22 16:16:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cardiol Therapeutics Inc Class A earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-416.5%+416.5%
5Y-416.5%10Y-308.5%-108.0%
4.3.1.2. Return on Assets

Shows how efficient Cardiol Therapeutics Inc Class A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • -25.0% Return on Assets means that Cardiol Therapeutics Inc Class A generated $-0.25 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is -25.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -22.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.0%TTM-22.3%-2.8%
TTM-22.3%YOY-12.0%-10.3%
TTM-22.3%5Y-20.4%-1.8%
5Y-20.4%10Y-20.8%+0.4%
4.3.1.3. Return on Equity

Shows how efficient Cardiol Therapeutics Inc Class A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • -42.9% Return on Equity means Cardiol Therapeutics Inc Class A generated $-0.43 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is -42.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -33.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-42.9%TTM-33.2%-9.7%
TTM-33.2%YOY-14.2%-19.0%
TTM-33.2%5Y-24.8%-8.4%
5Y-24.8%10Y-28.1%+3.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cardiol Therapeutics Inc Class A.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cardiol Therapeutics Inc Class A is operating .

  • Measures how much profit Cardiol Therapeutics Inc Class A makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-397.4%+397.4%
5Y-397.4%10Y-294.4%-103.0%
4.3.2.2. Operating Ratio

Measures how efficient Cardiol Therapeutics Inc Class A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y4.128-4.128
5Y4.12810Y3.058+1.070
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cardiol Therapeutics Inc Class A.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cardiol Therapeutics Inc Class A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.39 means the company has $2.39 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 2.394. The company is able to pay all its short-term debts. +1
  • The TTM is 3.711. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.394TTM3.711-1.317
TTM3.711YOY6.537-2.826
TTM3.7115Y9.243-5.531
5Y9.24310Y10.028-0.785
4.4.3.2. Quick Ratio

Measures if Cardiol Therapeutics Inc Class A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.24 means the company can pay off $2.24 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 2.245. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.559. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.245TTM3.559-1.314
TTM3.559YOY6.341-2.782
TTM3.5595Y7.381-3.822
5Y7.38110Y7.925-0.544
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cardiol Therapeutics Inc Class A.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cardiol Therapeutics Inc Class A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cardiol Therapeutics Inc Class A to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.42 means that Cardiol Therapeutics Inc Class A assets are financed with 41.6% credit (debt) and the remaining percentage (100% - 41.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 0.416. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.298. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.416TTM0.298+0.118
TTM0.298YOY0.153+0.145
TTM0.2985Y0.151+0.147
5Y0.15110Y0.208-0.057
4.5.4.2. Debt to Equity Ratio

Measures if Cardiol Therapeutics Inc Class A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 71.3% means that company has $0.71 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 0.713. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.450. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.713TTM0.450+0.263
TTM0.450YOY0.182+0.268
TTM0.4505Y0.195+0.255
5Y0.19510Y0.611-0.416
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cardiol Therapeutics Inc Class A generates.

  • Above 15 is considered overpriced but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -8.24 means the investor is paying $-8.24 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cardiol Therapeutics Inc Class A:

  • The EOD is -7.864. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.241. Based on the earnings, the company is expensive. -2
  • The TTM is -5.134. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.864MRQ-8.241+0.377
MRQ-8.241TTM-5.134-3.108
TTM-5.134YOY-2.561-2.572
TTM-5.1345Y-8.819+3.685
5Y-8.81910Y-8.904+0.085
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cardiol Therapeutics Inc Class A:

  • The EOD is -10.844. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.364. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.235. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.844MRQ-11.364+0.520
MRQ-11.364TTM-7.235-4.130
TTM-7.235YOY-3.236-3.999
TTM-7.2355Y-13.191+5.956
5Y-13.19110Y-12.627-0.564
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cardiol Therapeutics Inc Class A is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Cardiol Therapeutics Inc Class A:

  • The EOD is 13.496. Based on the equity, the company is expensive. -2
  • The MRQ is 14.144. Based on the equity, the company is expensive. -2
  • The TTM is 7.429. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD13.496MRQ14.144-0.648
MRQ14.144TTM7.429+6.715
TTM7.429YOY1.635+5.793
TTM7.4295Y8.809-1.380
5Y8.80910Y8.536+0.272
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets26,313
Total Liabilities10,951
Total Stockholder Equity15,361
 As reported
Total Liabilities 10,951
Total Stockholder Equity+ 15,361
Total Assets = 26,313

Assets

Total Assets26,313
Total Current Assets25,882
Long-term Assets431
Total Current Assets
Cash And Cash Equivalents 24,021
Net Receivables 242
Other Current Assets 1,618
Total Current Assets  (as reported)25,882
Total Current Assets  (calculated)25,882
+/-0
Long-term Assets
Property Plant Equipment 263
Intangible Assets 168
Long-term Assets  (as reported)431
Long-term Assets  (calculated)431
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,809
Long-term Liabilities143
Total Stockholder Equity15,361
Total Current Liabilities
Short-term Debt 22
Other Current Liabilities 10,787
Total Current Liabilities  (as reported)10,809
Total Current Liabilities  (calculated)10,809
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt143
Long-term Liabilities  (as reported)143
Long-term Liabilities  (calculated)143
+/- 0
Total Stockholder Equity
Common Stock152,350
Retained Earnings -158,347
Other Stockholders Equity 21,359
Total Stockholder Equity (as reported)15,361
Total Stockholder Equity (calculated)15,361
+/-0
Other
Capital Stock152,350
Cash and Short Term Investments 24,021
Common Stock Shares Outstanding 68,751
Liabilities and Stockholders Equity 26,313
Net Debt -23,857
Net Invested Capital 15,361
Net Working Capital 15,073
Property Plant and Equipment Gross 1,001
Short Long Term Debt Total 164



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
0
0
3,221
0
12,144
13,094
24,685
22,914
20,535
18,304
15,503
13,351
27,421
24,455
15,893
21,098
36,750
31,732
87,876
79,432
74,265
68,359
62,029
52,685
47,169
43,053
36,701
31,126
26,313
26,31331,12636,70143,05347,16952,68562,02968,35974,26579,43287,87631,73236,75021,09815,89324,45527,42113,35115,50318,30420,53522,91424,68513,09412,14403,22100
   > Total Current Assets 
0
0
2,485
2,357
11,453
12,418
24,027
22,271
19,627
17,199
14,371
12,257
26,383
23,467
14,950
20,209
35,916
30,940
87,140
78,735
73,619
67,758
61,438
52,109
46,647
42,450
36,153
30,637
25,882
25,88230,63736,15342,45046,64752,10961,43867,75873,61978,73587,14030,94035,91620,20914,95023,46726,38312,25714,37117,19919,62722,27124,02712,41811,4532,3572,48500
       Cash And Cash Equivalents 
0
0
2,357
-2,357
11,179
11,665
16,732
14,295
12,455
10,104
6,956
4,497
19,434
16,547
14,025
18,004
32,719
28,652
83,899
74,844
70,454
65,532
59,470
49,468
44,942
40,540
34,870
28,573
24,021
24,02128,57334,87040,54044,94249,46859,47065,53270,45474,84483,89928,65232,71918,00414,02516,54719,4344,4976,95610,10412,45514,29516,73211,66511,179-2,3572,35700
       Short-term Investments 
0
0
0
4,713
0
0
0
0
0
0
0
0
0
0
0
62
62
62
62
62
0
62
62
62
62
62
62
0
0
0062626262626206262626262000000000004,713000
       Net Receivables 
0
0
102
0
149
326
461
634
452
590
928
1,093
176
282
220
316
684
385
407
486
404
452
480
408
305
290
280
317
242
2423172802903054084804524044864073856843162202821761,093928590452634461326149010200
       Other Current Assets 
0
0
27
0
274
426
489
4,615
5,476
5,386
5,368
5,502
5,845
5,693
687
1,871
2,512
1,903
2,834
3,405
2,762
1,773
1,488
2,233
1,400
1,620
941
1,747
1,618
1,6181,7479411,6201,4002,2331,4881,7732,7623,4052,8341,9032,5121,8716875,6935,8455,5025,3685,3865,4764,61548942627402700
   > Long-term Assets 
0
0
736
-2,357
691
677
658
643
908
1,104
1,132
1,094
1,038
988
943
889
834
791
736
698
646
601
591
576
522
603
547
489
431
4314895476035225765916016466987367918348899439881,0381,0941,1321,104908643658677691-2,35773600
       Property Plant Equipment 
0
0
19
0
16
23
26
32
318
535
584
567
533
503
480
446
413
391
356
339
309
285
296
303
269
372
337
300
263
2633003373722693032962853093393563914134464805035335675845353183226231601900
       Intangible Assets 
0
0
717
0
675
654
633
611
590
569
548
527
506
485
464
443
421
400
379
358
337
316
295
274
253
231
210
189
168
168189210231253274295316337358379400421443464485506527548569590611633654675071700
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000
> Total Liabilities 
0
0
367
0
11,219
16,303
2,411
977
950
1,658
831
826
1,314
1,983
2,623
2,859
3,012
2,646
11,638
10,218
11,413
9,682
9,827
7,130
8,419
8,182
8,454
11,067
10,951
10,95111,0678,4548,1828,4197,1309,8279,68211,41310,21811,6382,6463,0122,8592,6231,9831,3148268311,6589509772,41116,30311,219036700
   > Total Current Liabilities 
0
0
177
0
1,168
3,725
2,141
977
796
1,510
691
695
1,191
1,869
2,518
2,764
2,927
2,572
11,565
10,158
11,365
9,646
9,805
7,121
8,419
8,030
8,295
10,916
10,809
10,80910,9168,2958,0308,4197,1219,8059,64611,36510,15811,5652,5722,9272,7642,5181,8691,1916956911,5107969772,1413,7251,168017700
       Short-term Debt 
0
0
0
0
0
0
0
0
49
50
50
51
52
52
52
52
52
53
45
47
48
49
50
52
48
29
16
16
22
22161629485250494847455352525252525150504900000000
       Accounts payable 
0
0
165
0
989
1,112
1,988
823
571
900
561
536
902
1,076
1,770
2,177
2,210
1,737
4,188
4,947
6,721
6,911
8,349
5,944
6,678
6,911
7,625
8,436
0
08,4367,6256,9116,6785,9448,3496,9116,7214,9474,1881,7372,2102,1771,7701,0769025365619005718231,9881,112989016500
       Other Current Liabilities 
0
0
11
0
179
2,613
154
153
747
1,460
640
643
1,139
1,817
2,466
2,712
2,875
2,519
11,520
10,111
11,317
9,597
9,754
7,069
8,371
8,001
8,280
2,464
10,787
10,7872,4648,2808,0018,3717,0699,7549,59711,31710,11111,5202,5192,8752,7122,4661,8171,1396436401,4607471531542,61317901100
   > Long-term Liabilities 
0
0
190
0
10,052
12,578
269
0
154
149
140
132
123
114
105
95
85
75
73
61
48
35
22
9
0
152
159
151
143
143151159152092235486173758595105114123132140149154026912,57810,052019000
       Long term Debt Total 
0
0
0
0
0
0
0
0
154
149
140
132
123
114
105
95
85
75
73
61
48
35
22
9
0
0
0
0
0
000009223548617375859510511412313214014915400000000
> Total Stockholder Equity
0
0
2,854
2,854
925
-3,209
22,274
21,937
19,585
16,646
14,672
12,525
26,107
22,473
13,270
18,239
33,737
29,085
76,238
69,214
62,852
58,677
52,202
45,556
38,750
34,871
28,247
20,059
15,361
15,36120,05928,24734,87138,75045,55652,20258,67762,85269,21476,23829,08533,73718,23913,27022,47326,10712,52514,67216,64619,58521,93722,274-3,2099252,8542,85400
   Common Stock
0
0
4,255
0
4,255
4,655
36,722
38,820
39,414
39,414
39,414
39,434
51,617
51,757
51,923
67,754
85,527
89,832
142,919
143,052
143,136
146,927
147,545
147,632
147,675
147,774
148,519
151,092
152,350
152,350151,092148,519147,774147,675147,632147,545146,927143,136143,052142,91989,83285,52767,75451,92351,75751,61739,43439,41439,41439,41438,82036,7224,6554,25504,25500
   Retained Earnings Total Equity00000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-3
2,854
259
-8
-10
-12
-29
-47
-76
-112
-148
-184
-221
-255
5,090
4,317
4,177
4,907
5,533
3,518
3,518
3,518
3,518
3,518
3,518
3,518
0
03,5183,5183,5183,5183,5183,5183,5185,5334,9074,1774,3175,090-255-221-184-148-112-76-47-29-12-10-82592,854-300
   Capital Surplus 
0
0
0
0
0
0
0
2,511
3,379
3,931
4,766
5,550
6,620
7,240
8,766
9,725
10,471
12,197
12,660
13,727
13,144
15,166
15,587
15,943
16,567
0
0
0
0
000016,56715,94315,58715,16613,14413,72712,66012,19710,4719,7258,7667,2406,6205,5504,7663,9313,3792,5110000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
263
0
259
625
3,117
4,176
4,889
5,459
6,574
7,389
12,449
13,113
13,448
11,529
15,561
12,197
12,660
13,727
13,144
18,683
15,587
19,461
16,567
18,519
18,786
17,206
21,359
21,35917,20618,78618,51916,56719,46115,58718,68313,14413,72712,66012,19715,56111,52913,44813,11312,4497,3896,5745,4594,8894,1763,117625259026300



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

Currency in CAD. All numbers in thousands.




6.5. Income Statements

Currency in CAD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-248
Gross Profit-248-248
 
Operating Income (+$)
Gross Profit-248
Operating Expense-29,537
Operating Income-29,786-29,786
 
Operating Expense (+$)
Research Development14,224
Selling General Administrative15,561
Selling And Marketing Expenses15,297
Operating Expense29,53745,083
 
Net Interest Income (+$)
Interest Income2,175
Interest Expense-0
Other Finance Cost-0
Net Interest Income2,175
 
Pretax Income (+$)
Operating Income-29,786
Net Interest Income2,175
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-28,128-31,443
EBIT - interestExpense = -29,785
-28,128
-28,128
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-29,785-28,128
Earnings Before Interest and Taxes (EBITDA)-29,537
 
After tax Income (+$)
Income Before Tax-28,128
Tax Provision-0
Net Income From Continuing Ops-28,006-28,128
Net Income-28,128
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses29,786
Total Other Income/Expenses Net1,657-2,175
 

Technical Analysis of Cardiol Therapeutics Inc Class A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cardiol Therapeutics Inc Class A. The general trend of Cardiol Therapeutics Inc Class A is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cardiol Therapeutics Inc Class A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cardiol Therapeutics Inc Class A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.71 < 2.71 < 3.57.

The bearish price targets are: 2.47 > 2.15 > 2.14.

Tweet this
Cardiol Therapeutics Inc Class A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cardiol Therapeutics Inc Class A. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cardiol Therapeutics Inc Class A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cardiol Therapeutics Inc Class A. The current macd is -0.05364943.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cardiol Therapeutics Inc Class A price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cardiol Therapeutics Inc Class A. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cardiol Therapeutics Inc Class A price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cardiol Therapeutics Inc Class A Daily Moving Average Convergence/Divergence (MACD) ChartCardiol Therapeutics Inc Class A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cardiol Therapeutics Inc Class A. The current adx is 26.02.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cardiol Therapeutics Inc Class A shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Cardiol Therapeutics Inc Class A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cardiol Therapeutics Inc Class A. The current sar is 2.7048.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cardiol Therapeutics Inc Class A Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cardiol Therapeutics Inc Class A. The current rsi is 47.51. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Cardiol Therapeutics Inc Class A Daily Relative Strength Index (RSI) ChartCardiol Therapeutics Inc Class A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cardiol Therapeutics Inc Class A. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cardiol Therapeutics Inc Class A price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cardiol Therapeutics Inc Class A Daily Stochastic Oscillator ChartCardiol Therapeutics Inc Class A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cardiol Therapeutics Inc Class A. The current cci is -1.88619931.

Cardiol Therapeutics Inc Class A Daily Commodity Channel Index (CCI) ChartCardiol Therapeutics Inc Class A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cardiol Therapeutics Inc Class A. The current cmo is -0.72971665.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cardiol Therapeutics Inc Class A Daily Chande Momentum Oscillator (CMO) ChartCardiol Therapeutics Inc Class A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cardiol Therapeutics Inc Class A. The current willr is -40.38461538.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cardiol Therapeutics Inc Class A is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Cardiol Therapeutics Inc Class A Daily Williams %R ChartCardiol Therapeutics Inc Class A Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cardiol Therapeutics Inc Class A.

Cardiol Therapeutics Inc Class A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cardiol Therapeutics Inc Class A. The current atr is 0.13612377.

Cardiol Therapeutics Inc Class A Daily Average True Range (ATR) ChartCardiol Therapeutics Inc Class A Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cardiol Therapeutics Inc Class A. The current obv is 42,949.

Cardiol Therapeutics Inc Class A Daily On-Balance Volume (OBV) ChartCardiol Therapeutics Inc Class A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cardiol Therapeutics Inc Class A. The current mfi is 59.15.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Cardiol Therapeutics Inc Class A Daily Money Flow Index (MFI) ChartCardiol Therapeutics Inc Class A Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cardiol Therapeutics Inc Class A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Cardiol Therapeutics Inc Class A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cardiol Therapeutics Inc Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.509
Ma 20Greater thanMa 502.597
Ma 50Greater thanMa 1002.728
Ma 100Greater thanMa 2002.804
OpenGreater thanClose2.510
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cardiol Therapeutics Inc Class A with someone you think should read this too:
  • Are you bullish or bearish on Cardiol Therapeutics Inc Class A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cardiol Therapeutics Inc Class A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cardiol Therapeutics Inc Class A

I send you an email if I find something interesting about Cardiol Therapeutics Inc Class A.


Comments

How you think about this?

Leave a comment

Stay informed about Cardiol Therapeutics Inc Class A.

Receive notifications about Cardiol Therapeutics Inc Class A in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.